ROSEBANK
INDUSTRIES PLC
AUDITED RESULTS FOR THE SEVEN
MONTH PERIOD ENDED 31 DECEMBER 2024
Rosebank Industries plc ("Rosebank"
or the "Company" or the "Group") today announces its audited
results for the seven month period ended 31 December
2024.
|
Adjusted1
results
|
Statutory
results
|
Operating loss
|
(1.6)
|
(9.5)
|
Free cash flow[1]
|
(0.6)
|
n/a
|
Cash and cash equivalents
|
48.1
|
48.1
|
·
A return to the "Buy, Improve, Sell" model
following a successful listing on AIM in July, which raised £50
million of seed capital from founders and key
shareholders
·
Disciplined capital management limiting the Group
to a free cash outflow1 of £0.6 million, retaining £48.1
million of the initial seed capital after deducting listing fees
and acquisition related costs
·
Adjusted1 operating loss of £1.6
million after establishing Head Office operations
·
Re-established the networks and financing sources
in search for the first acquisition and conducted due diligence on
potential targets in US, UK and Northern Europe
·
As announced earlier today, the Company is
currently in discussions in relation to a possible acquisition
of Electrical Components International,
Inc. ("ECI"), the predominantly US based,
market leading, manufacturing business providing critical
electrical solutions to a range of end markets
Enquiries:
Montfort Communications
Nick Miles
+44 7739 701 634,
miles@montfort.london
Charlotte McMullen
+44 7921 881
800, mcmullen@montfort.london
Investec Bank
plc
+44 (0)20 7597 5970
(Nominated Advisor, Joint Broker
& Financial Advisor)
Carlton Nelson
Christopher Baird
Chairman's
Statement
I am pleased to present Rosebank's
first set of results since its admission in July. The Board and the
Founders are excited to return the highly successful "Buy, Improve,
Sell" model to the public markets. With the welcome support
of our key shareholders, we were admitted to trading on AIM in
July, raising £50 million in initial capital. We have gained
a stellar register of investors, many of whom have been investors
in the Rosebank team previously. We thank them for their
support and look forward to delivering on the opportunities we are
seeking.
Dividend
As previously
stated, until completion of a major acquisition, the Directors do
not intend to pay a dividend. Following such an acquisition the
Directors will determine an appropriate dividend policy.
Consequently, the Board has confirmed that there will be no final
dividend for the period since admission.
Purpose, business model and strategy
Rosebank is executing its "Buy,
Improve, Sell" strategy, whereby it seeks to acquire good
engineering businesses with strong market positions that would
benefit from an improvement in their performance, with a view to
investing in those businesses and empowering their management teams
to unlock improvements and drive value and performance to generate
an above average return for shareholders and ongoing benefits for
wider stakeholders. Our preference is for businesses that are
approximately $3 billion in enterprise value that are headquartered
in either the US, the UK or Northern Europe.
We intend to do overlapping
acquisitions, seeking subsequent opportunities once we are
confident improvements are substantially underway in any existing
businesses, although we may be quicker with the second acquisition
in recognition of the additional initial bandwidth until multiple
businesses are in the Group.
Possible transaction
As announced earlier today, the
Company is in discussions with
Cerberus Capital Management, LP.
("Cerberus"), regarding a possible transaction
(the "Transaction").
The potential terms of the
Transaction remain confidential at this stage, however the Company
notes that the possible Transaction is in line with its acquisition
criteria and, if it proceeds, would be funded through a combination
of a fully underwritten equity issue (the "Fundraise") and new debt
facilities. A
further announcement will be made, as and when
required.
Governance
The Board has initially established
a strong corporate governance framework appropriate to the size and
nature of the Group at this time, supporting the Board in its
decision-making for the benefit of shareholders and wider
stakeholders. Further details are set out in the Corporate
Governance Report, which confirms the Company's intention to phase
implementation of the UK Corporate Governance Code in full after it
makes its first acquisition.

Justin Dowley
Non-Executive Chairman
19 February 2025
CEO Review
Immediately after admission, our
attention shifted to finding and securing an appropriate business
for our first acquisition, with the preference being approximately
$3 billion in enterprise value and headquartered in the US, the UK
or Northern Europe. Our time in the market since then has
already confirmed our confidence that there are plenty of
opportunities available for our "Buy, Improve, Sell" model to
achieve further success in our new home. The focus remains
sharply on securing the first acquisition.
The Company is seeking businesses
with strong underlying fundamentals and robust competitive
positioning, but with scope for improvement. Rosebank intends to
create value primarily through eliminating unnecessary corporate
overheads; changing the focus of management teams and incentivising
those management teams well; driving sustainable improvement;
focusing on profitability and cash generation; and reinvesting
heavily to drive long-term performance. We look forward to
delivering this both for our shareholders and the businesses we
acquire.
Outlook
The Board is very excited about the
opportunities for Rosebank and look forward to creating shareholder
value in the years to come.

Simon Peckham
Chief Executive Officer
19 February 2025
Finance Directors
Review
The statutory results of the Group
for the seven month period ended 31 December 2024 show an operating
loss of £9.5 million and a loss before tax of £8.6 million. The
adjusted results for the Group, shown on the face of the Income
Statement are adjusted to exclude certain items which are
significant in size or volatility or by nature are non-trading or
non-recurring. It is the Group's accounting policy to exclude these
items from the adjusted results, which are used as an Alternative
Performance Measure ("APM") as described by the European Securities
and Markets Authority ("ESMA"). APMs used by the Group are defined
in the glossary to the Consolidated Financial
Statements.
Despite the Group being in a
pre-acquisition phase, the Rosebank Board has consistently applied
the classification and presentation of adjusting items in this
initial reporting period. The adjusted results are considered to be
an important measure used to monitor how the businesses are
performing as they present a consistent and comparable set of
results between different reporting periods.
The adjusted results for the period
ended 31 December 2024 show an operating loss of £1.6 million and a
loss after tax of £0.7 million. Given the Group structure during
the period all results relate to Corporate costs and there are no
other reporting segments.
Reconciliation of statutory results to adjusted
results
The following table reconciles the
Group statutory operating loss to adjusted operating
loss:
|
Seven
month
period
ended
31 December
2024
£m
|
Statutory operating loss
|
(9.5)
|
Adjusting items:
|
|
Acquisition related costs
|
4.1
|
Equity-settled compensation scheme
charges
|
3.8
|
Adjustments to statutory operating loss
|
7.9
|
|
|
Adjusted operating loss
|
(1.6)
|
Adjusting items to the statutory
operating loss include:
·
Directly attributable third party acquisition
related costs of £4.1 million, including such costs incurred during
acquisition processes that did not complete. These are excluded
from adjusted results due to their size and non-trading
nature.
·
The charge for the Rosebank equity-settled
compensation schemes of £3.8 million, which includes a charge
related to employer's tax payable of £0.2 million. This is excluded
from adjusted results due to its size and volatility. The shares
that would be issued, based on the scheme's current valuation at
the end of the year, are included in the calculation of the
adjusted diluted earnings per share.
Finance costs and income
The finance income in the statutory
IFRS results for the period ended 31 December 2024 was £0.9
million, which included interest on bank balances and deposits held
in short term money market funds.
Tax
The tax charge shown in the
statutory results on a statutory loss before tax of £8.6 million is
£nil. A tax credit was not recognised as it was determined there
are not currently sufficient future profits anticipated to recover
any deferred tax asset for unused losses.
Cash management
On admission to AIM, seed capital
proceeds of £50.0 million were raised by the Group, and after
paying £1.1 million in associated costs of raising capital, £0.2
million of acquisition related costs, along with a free cash
outflow in the period of £0.6 million, the Group held a cash
balance of £48.1 million at 31 December 2024.
An analysis of free cash flow in the
period is shown in the table below:
|
Seven
month
period
ended
31 December
2024
£m
|
Adjusted operating loss
|
(1.6)
|
Working capital movements
|
0.3
|
Adjusted operating cash flow
|
(1.3)
|
Interest
|
0.7
|
Free cash flow
|
(0.6)
|
Free cash flow for the Group in the
seven month period ended 31 December 2024 was an outflow of £0.6
million, which included an adjusted operating cash outflow of £1.3
million, primarily related to Head office activities, partially
offset by interest received in the period of £0.7
million.
Financial risk management
A risk management and internal
controls framework is in place for the Group which is reflective of
the Group's current size, as it seeks its initial
acquisition. The most significant financial risk for the
Group is currently considered to be liquidity. The Group holds
£48.1 million of cash at 31 December 2024 and therefore has
sufficient headroom to minimise any liquidity risk. The cash
balances are spread between two bank accounts and a top-tier rated
money market fund, diversifying counterparty risk.
Going Concern
As part of their consideration of
going concern, the Directors have reviewed the Group's future cash
forecasts. Considering the Group's current
cash position, the Directors consider it appropriate that the Group
can manage its business risks successfully and adopt a going
concern basis in preparing these Consolidated Financial
Statements.

Matthew Richards
Group Finance Director
19 February 2025
Cautionary
Statement
This announcement contains
statements that are, or may be deemed to be "forward-looking
statements". These forward-looking statements may be identified by
the use of forward-looking terminology, including the terms
"believes", "estimates", "plans", "projects", "anticipates",
"potential", "predicts", "expects", "intends", "may", "will",
"can", "likely" or "should" or, in each case, their negative or
other variations or comparable terminology, or by discussions of
strategy, plans, objectives, goals, future events or intentions.
Forward-looking statements may and often do differ materially from
actual results. Any forward-looking statements reflect the
Company's current view with respect to future events and are
subject to risks relating to future events and other risks,
uncertainties and assumptions relating to the business, results of
operations, financial position, liquidity, prospects, growth and
strategies of the Group. Forward-looking statements speak only as
of the date they are made.
In light of these risks,
uncertainties and assumptions, the events in the forward-looking
statements may not occur or the Company's or the Group's actual
results, performance or achievements of the Company might be
materially different from the expected results, performance or
achievements expressed or implied by such forward-looking
statements. Forward-looking statements contained in this
announcement speak only as at the date of this announcement. The
Company expressly disclaims any obligation or undertaking to update
these forward-looking statements contained in this announcement to
reflect any change in their expectations or any change in events,
conditions, or circumstances on which such statements are based
unless required to do so by applicable law, the Listing Rules and
the Disclosure Guidance and Transparency Rules of the FCA or
Regulation (EU) 596/2014 as it forms part of the domestic law of
the United Kingdom by virtue of the European Union (Withdrawal) Act
2018.
Consolidated Income Statement
|
Notes
|
Seven
month
period
ended
31 December
2024
£m
|
Operating expenses
|
|
(9.5)
|
Operating loss
|
3
|
(9.5)
|
Finance income
|
|
0.9
|
Loss before tax
Tax
|
4
|
(8.6)
-
|
Loss after tax for the period
|
|
(8.6)
|
Earnings per share
- Basic
- Diluted
|
5
5
|
(53.5p)
(53.5p)
|
Adjusted(1) results
|
|
|
Adjusted operating loss
Adjusted loss after tax
Adjusted basic earnings per
share
Adjusted diluted earnings per
share
|
3
3
5
5
|
(1.6)
(0.7)
(4.4p)
(4.4p)
|
(1) Defined in note 2.
There was no other comprehensive
income during the period, therefore a Statement of Other
Comprehensive Income has not been presented. The above results have
been derived from continuing operations.
Consolidated Statement of Cash Flows
|
Notes
|
Seven
month
period
ended
31 December
2024
£m
|
Operating activities
|
|
|
Net
cash used in operating activities
|
7
|
(1.5)
|
Investing activities
Interest received
|
|
0.7
|
Net
cash from investing activities
|
|
0.7
|
Financing activities
Cash proceeds from issuing
shares
Associated costs from issuing
shares
|
|
50.0
(1.1)
|
Net
cash from financing activities
|
|
48.9
|
Net
increase in cash and cash equivalents
Cash and cash equivalents at the
beginning of the period
|
|
48.1
-
|
Cash and cash equivalents at the end of the
period
|
|
48.1
|
Consolidated Balance Sheet
|
Notes
|
31
December
2024
£m
|
Non-current assets
Property, plant and
equipment
|
|
0.5
|
|
|
0.5
|
Current assets
Other receivables
Cash and cash equivalents
|
|
0.3
48.1
|
|
|
48.4
|
Total assets
|
|
48.9
|
Current liabilities
Trade and other payables
|
|
4.3
|
|
|
4.3
|
Net
current assets
|
|
44.1
|
Non-current liabilities
Lease obligations
Provisions
|
|
|
|
0.5
|
6
|
0.2
|
|
|
0.7
|
Total liabilities
|
|
5.0
|
Net
assets
|
|
43.9
|
Equity
Issued share capital
Retained earnings
|
|
48.9
(5.0)
|
Equity attributable to owners of the parent
|
|
43.9
|
The Financial Statements were
approved and authorised for issue by the Board of Directors on 19
February 2025 and were signed on its behalf by:

Simon
Peckham
Matthew Richards
Chief
Executive
Group Finance Director
19 February
2025
19 February 2025
Consolidated Statement of Changes in Equity
|
Issued
share capital
£m
|
Retained
earnings
£m
|
Equity
attributable to owners
of the parent
£m
|
At 31 May 2024
|
-
|
-
|
-
|
Loss for the period
|
-
|
(8.6)
|
(8.6)
|
Issue of new shares net of costs
paid(1)
Equity-settled share-based
payments
|
48.9
-
|
-
3.6
|
48.9
3.6
|
At
31 December 2024
|
48.9
|
(5.0)
|
43.9
|
(1) Further
information is set out in note 1.
Notes to the Financial Statements
1. Corporate
information
The financial information included
within this Preliminary Announcement does not constitute the
statutory accounts of Rosebank Industries plc ("the Company") for
the seven month period ended 31 December 2024 but is derived from
those accounts. Statutory accounts for the seven month period ended
31 December 2024 will be delivered in due course to the registrar
of companies with the Jersey Financial Statements Commission
("JSFC"). The auditor has reported on those Financial Statements;
their reports were unqualified, did not draw attention to any
matters by way of emphasis and did not contain a statement under
section 113B (3) or (6) of the Companies (Jersey) Law
1991.
Whilst the financial information
included in this Preliminary Announcement has been prepared on the
basis of the requirements of International Financial Reporting
Standards as issued by the IASB ("IFRS"), this announcement does
not itself contain sufficient information to comply with IFRS. The
Company expects to publish full Financial Statements that comply
with IFRS during April 2025.
Rosebank Industries plc is a public
listed group incorporated in Jersey. The Group's shares are traded
on AIM. The Group is required under AIM rule 19 to provide
shareholders with audited consolidated financial statements. The
Group is not required to present parent company
information.
The registered office address of
Rosebank Industries plc is 26 New Street, St Helier, Jersey JE2
3RA.
Corporate structure
Capital structure
On 11 July 2024 the shares of the
Company were admitted to trading on AIM, a market operated by the
London Stock Exchange plc. In addition to the 2 shares issued at
incorporation on 31 May 2024, the Company allotted a further
19,999,998 ordinary shares of nil par value at 250 pence each,
which resulted in a placed share capital balance of £48.9 million,
being proceeds received of £50.0 million, net of associated costs
of £1.1 million.
Going concern
The Consolidated Financial
Statements have been prepared on a going concern basis as the
Directors consider that adequate resources exist for the Company to
continue in operational existence for the foreseeable future.
Following receipt of initial seed capital proceeds of £50.0 million
in July 2024, the Group retains £48.1 million classified within
cash and cash equivalents as at 31 December 2024, which provides
significant funding for the ongoing Head office costs as well as
costs related to its search for a suitable acquisition.
The Group's liquidity and funding
arrangements are described in the Finance Director's
Review.
2. Alternative
performance measures
The Group presents Alternative
Performance Measures ("APMs") in addition to the statutory results
of the Group. These are presented in accordance with the Guidelines
on APMs issued by the European Securities and Markets Authority
("ESMA").
APMs used by the Group are set out
in the glossary to this Preliminary Announcement and the
reconciling items between statutory and adjusted results are listed
below and described in more detail in note 3.
Adjusted profit measures exclude
items which are significant in size or volatility or by nature are
non-trading or non-recurring.
On this basis, the following are the
principal items included within adjusting items impacting operating
profit and profit before tax:
· Acquisition and disposal related gains and losses including
such costs incurred during acquisition and disposal processes that
do not materialise; and
· The
charge for the Rosebank equity-settled compensation scheme,
including its associated employer's tax charge.
In addition to the items above,
adjusting items impacting profit after tax include:
· The
tax effects of adjustments to profit before tax.
The Board considers the adjusted
results to be an important measure used to monitor how the
businesses are performing as this provides a meaningful reflection
of how the businesses are managed and measured on a day-to-day
basis. As the size and complexity of the Group increases, these
measures are intended to achieve consistency and comparability
between future reporting periods. For the seven month period ended
31 December 2024, the Board has used the adjusted measures to
monitor the underlying cost base of the Group as it establishes its
Head office operations.
The adjusted measures are also in
alignment with performance measures used by certain external
stakeholders.
Adjusted profit is not a defined
term under IFRS and may not be comparable with similarly titled
profit measures reported by other companies. It is not
intended to be a substitute for, or superior to, GAAP measures. All
APMs relate to the current period results.
3.
Reconciliation of adjusted profit measures
As described in note 2, adjusted
profit measures are an alternative performance measure used by the
Board to monitor the operating performance of the Group.
a) Operating
profit
|
Notes
|
Seven
month
period
ended
31 December
2024
£m
|
Operating loss
|
|
(9.5)
|
Rosebank equity-settled compensation
scheme charges
Acquisition and disposal related
gains and losses
|
a
b
|
3.8
4.1
|
Total adjustments to operating
loss
|
|
7.9
|
Adjusted operating loss
|
|
(1.6)
|
a. The charge for the
Rosebank Incentive Schemes equity-settled Employee Share Scheme of
£3.8 million, which includes a charge to the accrual for employer's
tax payable of £0.2 million, is excluded from adjusted results
due to its size and volatility. The shares that would be issued,
based on the current value of both schemes at the end of the
reporting period, are included in the calculation of the
adjusted diluted earnings per share.
b. An acquisition and
disposal related charge of £4.1 million arose in the period which
relates to costs incurred in respect of acquisition processes.
These are shown as adjusting items due to their size and
non-trading nature.
b) Profit after
tax
|
|
Seven
month
period
ended
31 December
2024
£m
|
Loss after tax
|
|
(8.6)
|
Adjustments to operating loss as
above
Tax effect of adjustments to loss
before tax
|
|
7.9
-
|
Total adjustments to loss after
tax
|
|
7.9
|
Adjusted loss after tax
|
|
(0.7)
|
4. Tax
The tax charge for the period can be
reconciled to the loss before tax per the Income Statement as
follows:
|
Seven
month
period
ended
31 December
2024
£m
|
Loss before tax
|
(8.6)
|
Tax credit on loss before tax at
19%
Tax effect of:
Non-deductible and non-taxable
items
|
1.6
(1.6)
|
Total tax charge for the period
|
-
|
The reconciliation has been
performed at a tax rate of 19% as results in the period arose in
the UK and as such the UK small profits rate has been
used.
Global Minimum Tax rules
The Group has reviewed the impact of
the new Global Minimum Tax ("Pillar 2") rules and considers they
are unlikely to have a material impact on the Group tax charge
in their current form.
5. Earnings per
share
Earnings attributable to owners of
the parent
|
Seven
month
period
ended
31 December
2024
£m
|
Earnings for basis of earnings per
share
|
(8.6)
|
|
Seven
month
period
ended
31 December
2024
Number
|
Weighted average number of ordinary
shares for the purposes of basic earnings per share
(million)
Further shares for the purposes of
diluted earnings per share (million)
|
16
-
|
Weighted average number of ordinary shares for the purposes of
diluted earnings per share (million)
|
16
|
On 11 July 2024, the Company was
admitted to trading on AIM. The Company allotted a further
19,999,998 Ordinary shares, in addition to the 2 shares issued at
incorporation.
Earnings per share
|
Seven
month
period
ended
31 December
2024
pence
|
Basic earnings per share
|
(53.5)
|
Diluted earnings per
share
|
(53.5)
|
Adjusted earnings
|
Seven
month
period
ended
31 December
2024
£m
|
Adjusted earnings for the basis of
adjusted earnings per share
|
(0.7)
|
Adjusted earnings per
share:
|
Seven
month
period
ended
31 December
2024
pence
|
Adjusted basic earnings per
share
Adjusted diluted earnings per
share
|
(4.4)
(4.4)
|
6. Provisions
|
31
December
2024
£m
|
At 31 May 2024
Charge to operating
profit(1)
|
-
0.2
|
At
31 December 2024
|
0.2
|
Current
Non-current
|
-
0.2
|
|
0.2
|
(1) Recognised in adjusting items
(see note 3).
As at 31 December 2024, a provision
has been recognised for the employer tax on equity-settled
incentive schemes, which is expected to result in cash expenditure
during the next three to six years.
The effect of discounting on
provisions is not considered to be material to the
Group.
7. Cash flow
statement
|
Notes
|
Seven
month
period
ended
31 December
2024
£m
|
Reconciliation of operating loss to
net cash used in operating activities
|
|
|
Operating loss
Adjusting items
|
3
|
(9.5)
7.9
|
Adjusted operating loss
Adjustments for:
Change in receivables
Change in payables
Acquisition related costs
|
3
|
(1.6)
(0.1)
0.4
(0.2)
|
Net
cash used in operating activities
|
|
(1.5)
|
Glossary
Alternative Performance Measures
("APMs")
In accordance with the Guidelines on
APMs issued by the European Securities and Markets Authority
("ESMA"), additional information is provided on the APMs used by
the Group below.
In the reporting of financial
information, the Group uses certain measures that are not required
under IFRS. These additional measures (commonly referred to as
APMs) provide additional information on the performance of the
business and trends to stakeholders. The Board considers the
adjusted results to be an important measure used to monitor how the
businesses are performing as this provides a meaningful reflection
of how the businesses are managed and measured on a day-to-day
basis. As the size and complexity of the Group increases, these
measures are intended to achieve consistency and comparability
between future reporting periods. For the seven month period ended
31 December 2024, the Board has used the adjusted measures to
monitor the underlying cost base of the Group as it establishes its
Head office operations.
These APMs may not be directly
comparable with similarly titled measures reported by other
companies and they are not intended to be a substitute for, or
superior to, IFRS measures. All Income Statement and cash flow
measures are provided for continuing operations.
Income Statement Measures
APM
Adjusting items
|
Closest equivalent statutory
measure
None
|
Reconciling items to statutory
measure
Adjusting items (note 3)
|
Definition and purpose
Those items which the Group excludes
from its adjusted profit metrics in order to present a further
measure of the Group's performance.
These include items which are
significant in size or volatility or by nature are non-trading or
non-recurring.
This provides a meaningful
comparison of how the businesses are managed and measured on a
day-to-day basis and provides consistency and comparability
between reporting periods.
|
APM
Adjusted operating profit
|
Closest equivalent statutory
measure
Operating
profit/(loss)(1)
|
Reconciling items to statutory
measure
Adjusting items (note 3)
|
Definition and purpose
The Group uses adjusted profit
measures to provide a useful and more comparable measure of the
ongoing performance of the Group. Adjusted measures are
reconciled to statutory measures by removing adjusting items, the
nature of which are disclosed above and further detailed in note
3.
|
|
Adjusted operating profit
|
Seven
month
period
ended
31 December
2024
£m
|
Operating loss
Adjusting items to operating loss
(note 3)
|
(9.5)
7.9
|
Adjusted operating profit
|
(1.6)
|
APM
Adjusted profit after tax
|
Closest equivalent statutory
measure
Profit/(loss) after tax
|
Reconciling items to statutory
measure
Adjusting items (note 3)
|
Definition and purpose
Profit after tax but before the
impact of the adjusting items. As discussed above, adjusted profit
measures are used to provide a useful and more comparable measure
of the ongoing performance of the Group. Adjusted measures are
reconciled to statutory measures by removing adjusting items, the
nature of which are disclosed above and further detailed in note
3.
|
|
Adjusted profit after tax
|
Seven
month
period
ended
31 December
2024
£m
|
Profit/(loss) after tax
Adjusting items to profit/(loss)
after tax (note 3)
|
(8.6)
7.9
|
Adjusted profit after tax
|
(0.7)
|
APM
Adjusted basic earnings per
share
|
Closest equivalent statutory
measure
Basic earnings per share
|
Reconciling items to statutory
measure
Adjusting items (note 3 and note
5)
|
Definition and purpose
Profit after tax attributable to
owners of the parent and before the impact of adjusting items,
divided by the weighted average number of ordinary shares in issue
during the financial period.
|
APM
Adjusted diluted earnings per
share
|
Closest equivalent statutory
measure
Diluted earnings per
share
|
Reconciling items to statutory
measure
Adjusting items (note 3 and note
5)
|
Definition and purpose
Profit after tax attributable to
owners of the parent and before the impact of adjusting items,
divided by the weighted average number of ordinary shares in issue
during the financial period adjusted for the effects of any
potentially dilutive options.
|
Cash Flow Measures
APM
Adjusted operating cash
flow
|
Closest equivalent statutory
measure
Net cash from operating
activities
|
Reconciling items to statutory
measure
Acquisition related costs (note
7)
|
Definition and purpose
This measure provides additional
useful information in respect of cash generation and is consistent
with how business performance is
measured internally.
|
|
Adjusted operating cash
flow
|
Seven
month
period
ended
31 December
2024
£m
|
Net cash used in operating
activities
Acquisition related costs
|
(1.5)
0.2
|
Adjusted operating cash
flow
|
(1.3)
|
APM
Free cash flow
|
Closest equivalent statutory
measure
Net increase/decrease in cash and
cash equivalents
|
Reconciling items to statutory
measure
Acquisition related costs, cash
proceeds from issuing shares and associated costs from issuing
shares
|
Definition and purpose
Free cash flow represents cash
generated after all trading costs.
|
|
Free cash flow
|
Seven
month
period
ended
31 December
2024
£m
|
Net increase in cash and cash
equivalents
Acquisition related costs
Cash proceeds from issuing
shares
Associated costs from issuing
shares
|
48.1
0.2
(50.0)
1.1
|
Free cash flow
|
(0.6)
|
(1) Operating profit/(loss) is not
defined within IFRS but is a widely accepted profit measure being
profit/(loss) before finance costs, finance income and
tax.